Last Updated: May 2, 2026

calcium chloride; potassium chloride; sodium chloride - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for calcium chloride; potassium chloride; sodium chloride and what is the scope of freedom to operate?

Calcium chloride; potassium chloride; sodium chloride is the generic ingredient in two branded drugs marketed by B Braun, Baxter Hlthcare, Otsuka Icu Medcl, Abbott, Fresenius Kabi Usa, and Miles, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

Summary for calcium chloride; potassium chloride; sodium chloride
US Patents:0
Tradenames:2
Applicants:6
NDAs:20

US Patents and Regulatory Information for calcium chloride; potassium chloride; sodium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun RINGER'S IN PLASTIC CONTAINER calcium chloride; potassium chloride; sodium chloride INJECTABLE;INJECTION 018721-001 Nov 9, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
B Braun RINGER'S IN PLASTIC CONTAINER calcium chloride; potassium chloride; sodium chloride INJECTABLE;INJECTION 020002-001 Apr 17, 1992 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare RINGER'S IN PLASTIC CONTAINER calcium chloride; potassium chloride; sodium chloride INJECTABLE;INJECTION 016693-001 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Otsuka Icu Medcl RINGER'S IN PLASTIC CONTAINER calcium chloride; potassium chloride; sodium chloride INJECTABLE;INJECTION 018251-001 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Calcium chloride; potassium chloride; sodium chloride Market Analysis and Financial Projection

Last updated: February 4, 2026

Investment Scenario and Fundamentals Analysis for Calcium Chloride, Potassium Chloride, and Sodium Chloride

This analysis evaluates key market dynamics, production fundamentals, regulatory factors, and investment considerations for calcium chloride, potassium chloride, and sodium chloride—salts primarily used in medical, industrial, and agricultural sectors.


What Is the Market Size and Demand Outlook?

Compound Estimated Global Market (2022) Growth Rate (CAGR 2022-2029) Major End-Use Segments
Calcium Chloride $300 million 3.1% Medical (desiccants, orthopedics), de-icing, food processing
Potassium Chloride $4 billion 4.2% Fertilizers (primary), food additive, pharmaceutical
Sodium Chloride $2.4 billion 2.5% Food, industrial chemicals, de-icing, water treatment

Sources: MarketsandMarkets [1], Grand View Research [2].

Additional demand drivers include rising agricultural needs for potassium fertilizers, increasing sodium chloride usage in de-icing amid changing climates, and expanding medical applications for calcium chloride.

How Do Supply and Production Dynamics Influence Investment?

Compound Key Production Regions Major Producers Supply Risks
Calcium Chloride North America, China Olin Corporation, Lovibond, Akti-Phos Dependence on regional waste streams and salt production; environmental regulations
Potassium Chloride Canada, Russia, Belarus, Chile Nutrien, Koch Fertilizer, Uralkali Political stability, export restrictions, geopolitical tensions
Sodium Chloride U.S., China, Australia, Germany Cargill, Compass Minerals, AkzoNobel Salt overcapacity, environmental permits

Production relies heavily on natural brine resources and salt deposits; geopolitical and environmental factors can cause supply disruptions, impacting pricing and investment returns.

What Are the Regulatory and Environmental Factors?

Compound Key Regulations and Policies Environmental Concerns Impact on Investment
Calcium Chloride FDA for medical use, OSHA for industrial safety Waste disposal, water contamination Regulatory approvals essential in medical and industrial applications
Potassium Chloride Fertilizer standards, export controls Mineral extraction impact Stringent standards in agriculture and trade can influence margins
Sodium Chloride Food safety authorities (FDA, EFSA), environmental regulations Brine discharge, land use Compliance adds costs; export restrictions may influence margins

Changes in regulations, especially concerning environmental impact and safety, can modify production costs and market access.

What Are Key Investment Considerations?

  • Market Growth: Potassium chloride exhibits the highest CAGR and largest market size, driven by demand for fertilizers.
  • Supply Risks: Geopolitical tensions affecting major producers (e.g., Russia, Belarus) could constrain supply, raising prices.
  • Regulatory Environment: Stringent regulations for environmental protection could impose additional costs or limit production scaling.
  • Technological Development: Innovations in extraction and production processes may lower costs or create new applications.

How Competitive Is the Industry?

Company Market Share (2022) Competitive Advantages
Nutrien 20% Integrated supply chain, extensive reserves
Cargill 15% Diversified product portfolio, global reach
Kemira 10% Specialty applications, R&D capabilities

Barriers include high capital expenditure, access to natural resources, and regulatory compliance.

Financial Outlook and Investment Risks

  • Pricing Volatility: Susceptible to raw material price swings, especially for potassium and sodium salts.
  • Demand Stability: Long-term growth driven by agriculture and medical uses; cyclicality in industrial applications must be monitored.
  • Investment Suitability: Companies with diversified product portfolios and access to stable raw sources present lower risk. Pure salt producers face price and regulation volatility.

Key Takeaways

  • Potassium chloride is the most lucrative with a high CAGR and primary application in fertilizers.
  • Supply risks linked to geopolitical tensions can influence prices across all three compounds.
  • Environmental and regulatory compliance impose cost burdens but also serve as barriers to new entrants.
  • Industry leaders focus on integrated supply chains and R&D to maintain competitive advantage.
  • Price volatility remains a primary concern, requiring active risk management.

FAQs

1. What are the main drivers for growth in these salts' markets?
Demand growth in agriculture (potassium chloride), infrastructure and safety applications (calcium chloride), and food processing (sodium chloride) drive market expansion.

2. How sensitive are prices to geopolitical events?
Potassium chloride prices are highly sensitive due to concentration of production in a few countries; sanctions or export restrictions can significantly affect supply.

3. What environmental regulations impact these compounds?
Rules on waste disposal, water contamination, and land use influence production costs and capacity expansion potential.

4. Are there new technological developments affecting the industry?
Advances in brine extraction, process efficiencies, and alternative sources can lower production costs and open new applications.

5. Which companies are best positioned for investment?
Producers with vertical integration, diversified applications, and geographic stability—such as Nutrien—are typically more resilient.


References

[1] MarketsandMarkets, "Market for Calcium Chloride," 2022.
[2] Grand View Research, "Potassium Chloride Market," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.